Literature DB >> 28801345

Molecular basis for increased susceptibility of Indigenous North Americans to seropositive rheumatoid arthritis.

Stephen W Scally1, Soi-Cheng Law2, Yi Tian Ting1, Jurgen van Heemst3, Jeremy Sokolove4, Aaron J Deutsch5, E Bridie Clemens6, Antonis K Moustakas7, George K Papadopoulos8, Diane van der Woude3, Irene Smolik9, Carol A Hitchon9, David B Robinson9, Elizabeth D Ferucci10, Charles N Bernstein9, Xiaobo Meng9, Vidyanand Anaparti9, Tom Huizinga3, Katherine Kedzierska6, Hugh H Reid1, Soumya Raychaudhuri11,12,13,14, René E Toes3, Jamie Rossjohn1,15,16, Hani El-Gabalawy9, Ranjeny Thomas2.   

Abstract

OBJECTIVE: The pathogenetic mechanisms by which HLA-DRB1 alleles are associated with anticitrullinated peptide antibody (ACPA)-positive rheumatoid arthritis (RA) are incompletely understood. RA high-risk HLA-DRB1 alleles are known to share a common motif, the 'shared susceptibility epitope (SE)'. Here, the electropositive P4 pocket of HLA-DRB1 accommodates self-peptide residues containing citrulline but not arginine. HLA-DRB1 His/Phe13β stratifies with ACPA-positive RA, while His13βSer polymorphisms stratify with ACPA-negative RA and RA protection. Indigenous North American (INA) populations have high risk of early-onset ACPA-positive RA, whereby HLA-DRB1*04:04 and HLA-DRB1*14:02 are implicated as risk factors for RA in INA. However, HLA-DRB1*14:02 has a His13βSer polymorphism. Therefore, we aimed to verify this association and determine its molecular mechanism.
METHODS: HLA genotype was compared in 344 INA patients with RA and 352 controls. Structures of HLA-DRB1*1402-class II loaded with vimentin-64Arg59-71, vimentin-64Cit59-71 and fibrinogen β-74Cit69-81 were solved using X-ray crystallography. Vimentin-64Cit59-71-specific and vimentin59-71-specific CD4+ T cells were characterised by flow cytometry using peptide-histocompatibility leukocyte antigen (pHLA) tetramers. After sorting of antigen-specific T cells, TCRα and β-chains were analysed using multiplex, nested PCR and sequencing.
RESULTS: ACPA+ RA in INA was independently associated with HLA-DRB1*14:02. Consequent to the His13βSer polymorphism and altered P4 pocket of HLA-DRB1*14:02, both citrulline and arginine were accommodated in opposite orientations. Oligoclonal autoreactive CD4+ effector T cells reactive with both citrulline and arginine forms of vimentin59-71 were observed in patients with HLA-DRB1*14:02+ RA and at-risk ACPA- first-degree relatives. HLA-DRB1*14:02-vimentin59-71-specific and HLA-DRB1*14:02-vimentin-64Cit59-71-specific CD4+ memory T cells were phenotypically distinct populations.
CONCLUSION: HLA-DRB1*14:02 broadens the capacity for citrullinated and native self-peptide presentation and T cell expansion, increasing risk of ACPA+ RA. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  T cells; autoimmunity; rheumatoid arthritis

Mesh:

Substances:

Year:  2017        PMID: 28801345      PMCID: PMC6724216          DOI: 10.1136/annrheumdis-2017-211300

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  10 in total

1.  The interplay between citrullination and HLA-DRB1 polymorphism in shaping peptide binding hierarchies in rheumatoid arthritis.

Authors:  Yi Tian Ting; Jan Petersen; Sri H Ramarathinam; Stephen W Scally; Khai L Loh; Ranjeny Thomas; Anish Suri; Daniel G Baker; Anthony W Purcell; Hugh H Reid; Jamie Rossjohn
Journal:  J Biol Chem       Date:  2018-01-09       Impact factor: 5.157

2.  How MHC molecules grab citrullinated peptides to foster rheumatoid arthritis.

Authors:  David H Margulies
Journal:  J Biol Chem       Date:  2018-03-02       Impact factor: 5.157

Review 3.  HLA associations in inflammatory arthritis: emerging mechanisms and clinical implications.

Authors:  Robert Busch; Simon Kollnberger; Elizabeth D Mellins
Journal:  Nat Rev Rheumatol       Date:  2019-06       Impact factor: 20.543

4.  Flow Cytometric Clinical Immunomonitoring Using Peptide-MHC Class II Tetramers: Optimization of Methods and Protocol Development.

Authors:  Diahann T S L Jansen; Nishta Ramnoruth; Khai L Loh; Jamie Rossjohn; Hugh H Reid; Hendrik J Nel; Ranjeny Thomas
Journal:  Front Immunol       Date:  2018-01-22       Impact factor: 7.561

Review 5.  Infectious Triggers in Periodontitis and the Gut in Rheumatoid Arthritis (RA): A Complex Story About Association and Causality.

Authors:  Burkhard Möller; Florian Kollert; Anton Sculean; Peter M Villiger
Journal:  Front Immunol       Date:  2020-06-03       Impact factor: 7.561

Review 6.  Etiologies of Rheumatoid Arthritis: Update on Mucosal, Genetic, and Cellular Pathogenesis.

Authors:  Vanessa L Kronzer; John M Davis
Journal:  Curr Rheumatol Rep       Date:  2021-03-01       Impact factor: 4.592

Review 7.  Uranium Exposure in American Indian Communities: Health, Policy, and the Way Forward.

Authors:  Nicole Redvers; Ann Marie Chischilly; Donald Warne; Manuel Pino; Amber Lyon-Colbert
Journal:  Environ Health Perspect       Date:  2021-03-26       Impact factor: 9.031

8.  High resolution HLA-DRB1 analysis and shared molecular amino acid signature of DRβ1 molecules in Occult hepatitis B infection.

Authors:  Tianju Wang; Chunmei Shen; Hengxin Li; Liping Chen; Sheng Liu; Jun Qi
Journal:  BMC Immunol       Date:  2022-04-25       Impact factor: 3.594

9.  Disparate Effects of Invasive Group A Streptococcus on Native Americans.

Authors:  Ryan M Close; James B McAuley
Journal:  Emerg Infect Dis       Date:  2020-09       Impact factor: 6.883

10.  Impact of HLA-DR Antigen Binding Cleft Rigidity on T Cell Recognition.

Authors:  Christopher Szeto; Joseph I Bloom; Hannah Sloane; Christian A Lobos; James Fodor; Dhilshan Jayasinghe; Demetra S M Chatzileontiadou; Emma J Grant; Ashley M Buckle; Stephanie Gras
Journal:  Int J Mol Sci       Date:  2020-09-25       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.